A recent study by UCB Pharma, Covance Limited, Peptide Protein Research, and the University of Bath used Macromolecular Crystallography (MX) to study a specific part of bovine antibodies called cysteine-rich knob domains. These knob domains can work independently as small peptides and can be created through chemical synthesis.
By leveraging the advantages of bovine antibodies, researchers are able to tap into their unique characteristics to develop innovative and potentially more effective therapeutic agents. The use of bovine antibodies expands the repertoire of available antibody-based drugs, and reduces the adverse effects often associated with human antibodies.
By analysing the genetic information of the antibodies, these knob domain peptides can be made and modified quickly to improve their effectiveness as potential drugs. The study also explores how to make the knob domains more stable and last longer in the body.
This research presents a promising approach to developing new medicines by understanding and modifying these unique parts of bovine antibodies.
Diamond Light Source is the UK's national synchrotron science facility, located at the Harwell Science and Innovation Campus in Oxfordshire.
Copyright © 2022 Diamond Light Source
Diamond Light Source Ltd
Harwell Science & Innovation Campus
Diamond Light Source® and the Diamond logo are registered trademarks of Diamond Light Source Ltd
Registered in England and Wales at Diamond House, Harwell Science and Innovation Campus, Didcot, Oxfordshire, OX11 0DE, United Kingdom. Company number: 4375679. VAT number: 287 461 957. Economic Operators Registration and Identification (EORI) number: GB287461957003.